Stock Market News

FDA accepts Teva, Medincell's supplemental application for UZEDY as bipolar I disorder treatment

Feb 25, 2025 - 22:43
 0
Read More

Tags:

Previous Article

Instacart Q4 results miss expectations; shares dive in afterhours

Next Article

Australia's Lynas Rare Earths' first-half profit plunges on weak prices

Related Posts

Berkshire sells some DaVita shares, cuts stake to 45%

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 14, 2025  0

Capgemini posts 2024 sales slightly above estimates

Capgemini posts 2024 sales slightly above estimates

Feb 18, 2025  0

Indonesia, Apple reach deal to lift iPhone 16 ban – Blo...

Feb 25, 2025  0